ARTICLE
11 December 2019

Settlement Of Bellwether Cases And Appeal Of Negotiation Class Certification In In Re National Prescription Opiate Litigation

CG
Cleary Gottlieb Steen & Hamilton LLP

Contributor

Cleary Gottlieb Steen & Hamilton LLP logo
Cleary Gottlieb’s 1,300 lawyers from more than 50 countries work across practices, industries, jurisdictions, and continents to provide clients with simple, actionable approaches to their most complex legal and business challenges. Global corporations, financial institutions, sovereign governments, local businesses, and individuals come to us for consistently practical and forward-looking advice.
The parties expect that future bellwether trials in certain of the more than 2,000 suits in the MDL will be scheduled for the first quarter of 2020.
United States Litigation, Mediation & Arbitration
To print this article, all you need is to be registered or login on Mondaq.com.

Settlement Developments On October 21, 2019, drug distributors AmerisourceBergen Drug Corp., Cardinal Health Inc. and McKesson Corp. and manufacturer Teva Pharmaceuticals Industries Ltd. reached an approximately $260 million settlement with Summit and Cuyahoga counties in Ohio, avoiding what was poised to be a bellwether trial in the multi-district litigation ("MDL") arising out of the opioid crisis. The settlement money will be used to fund addiction treatment and prevention programs. The defendants did not admit to any wrongdoing as part of the settlement.41

The agreement between three of the nation's largest distributors and the manufacturer does not end the National Prescription Opiate Litigation that involves thousands of actions brought by cities, counties and American Indian tribes against companies connected to the production, distribution and marketing of opioids.

As trial approached, there were reports of a nearly $50 billion settlement for global resolution of the thousands of suits encompassing the MDL and those filed by various states. Rumors have surfaced that disputes over potentially massive attorney's fees have thwarted these talks.

Ohio's Attorney General David Yost has been a vocal critic of the cases, arguing that plaintiffs' counsel could recoup funds that would be better used to combat the opioid epidemic. Yost also asked the Sixth Circuit to stay the bellwether trial, claiming that the plaintiff municipalities were encroaching on the state's authority to guard the public welfare. The Sixth Circuit rejected that request less than two weeks before the trial's scheduled October 21, 2019 start.42

The parties expect that future bellwether trials in certain of the more than 2,000 suits in the MDL will be scheduled for the first quarter of 2020. These cases may now be less likely to see trial in light of the recent settlements.

Footnotes

41 See Sara Randazzo, Last-Minute Opioid Deal Could Open Door to Bigger Settlement, Wall St. J. (Oct. 21, 2019), https://www.wsj.com/articles/four-drug-companiesreach-last-minute-settlement-in-opioid-litigation-11571658212.

42 See Order, In re: State of Ohio, No. 19-3827 (6th Cir. Oct. 10, 2019), ECF No. 32-1.

To view original article, please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More